Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
YCBD 
cbdMD Inc (YCBD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: YCBD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $2
1 Year Target Price $2
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -43.58% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.58M USD | Price to earnings Ratio 1.45 | 1Y Target Price 2 |
Price to earnings Ratio 1.45 | 1Y Target Price 2 | ||
Volume (30-day avg) 1 | Beta 2.21 | 52 Weeks Range 0.47 - 6.54 | Updated Date 11/13/2025 |
52 Weeks Range 0.47 - 6.54 | Updated Date 11/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.51 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -7.96% | Operating Margin (TTM) -19.64% |
Management Effectiveness
Return on Assets (TTM) -9.44% | Return on Equity (TTM) -33.13% |
Valuation
Trailing PE 1.45 | Forward PE 714.29 | Enterprise Value 10606471 | Price to Sales(TTM) 0.56 |
Enterprise Value 10606471 | Price to Sales(TTM) 0.56 | ||
Enterprise Value to Revenue 0.56 | Enterprise Value to EBITDA 65.08 | Shares Outstanding 8912959 | Shares Floating 8757606 |
Shares Outstanding 8912959 | Shares Floating 8757606 | ||
Percent Insiders 16.09 | Percent Institutions 5.63 |
About cbdMD Inc
Exchange NYSE MKT | Headquaters Charlotte, NC, United States | ||
IPO Launch date 2019-04-29 | CEO, CFO, Principal Executive Officer & Director Mr. T. Ronan Kennedy | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 42 | Website https://www.cbdmd.com |
Full time employees 42 | Website https://www.cbdmd.com | ||
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.